Expression of microRNA-210 in gastric cancer and its relationship with clinicopathological factors and prognosis

俞鹏飞; 杜义安; 杨立涛

doi:10.19401/j.cnki.1007-3639.2017.03.006

您当前的位置：

首页 >

文章列表页 >

Expression of microRNA-210 in gastric cancer and its relationship with clinicopathological factors and prognosis

更新时间：2025-12-31

- Expression of microRNA-210 in gastric cancer and its relationship with clinicopathological factors and prognosis
- China Oncology Vol. 27, Issue 3, Pages: 197-200(2017)
- 作者机构：
  
  浙江省肿瘤医院腹部外科,浙江,杭州,310022
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2017.03.006
  CLC：
- Published Online：12 April 2017，
  
  Published：12 April 2017
- 稿件说明：
移动端阅览
俞鹏飞,杜义安,杨立涛,等. 胃癌组织中microRNA-210的表达与临床病理因素及预后关系的研究[J]. 中国癌症杂志, 2017, 27(3): 197-200.

俞鹏飞, 杜义安, 杨立涛. Expression of microRNA-210 in gastric cancer and its relationship with clinicopathological factors and prognosis[J]. China Oncology, 2017, 27(3): 197-200.
俞鹏飞,杜义安,杨立涛,等. 胃癌组织中microRNA-210的表达与临床病理因素及预后关系的研究[J]. 中国癌症杂志, 2017, 27(3): 197-200. DOI： 10.19401/j.cnki.1007-3639.2017.03.006.

俞鹏飞, 杜义安, 杨立涛. Expression of microRNA-210 in gastric cancer and its relationship with clinicopathological factors and prognosis[J]. China Oncology, 2017, 27(3): 197-200. DOI： 10.19401/j.cnki.1007-3639.2017.03.006.

摘要

背景与目的：miR-210与胃癌的发生、发展密切相关，但其作用机制及临床意义仍不明确。该研究旨在探讨miR-210在胃癌组织中的表达情况及其临床意义。方法：采用实时荧光定量聚合酶链反应(real-time fluorescent quantitative polymerase chain reaction，RTFQ-PCR)检测78例胃癌组织及相应的癌旁组织中miR-210的表达情况，分析其与临床病理因素及预后的关系。结果：RTFQ-PCR检查结果发现，miR-210在胃癌组织中的表达高于癌旁组织，两者相比差异有统计学意义(P0.05)。miR-210的表达与肿瘤大小、淋巴结转移及TNM分期密切相关，而与患者年龄、性别、肿瘤的分化程度及浸润深度等无关。miR-210低表达患者5年生存率为48.2%，miR-210高表达患者5年生存率为30.4%，差异有统计学意义(χ

=4.216，P=0.040)。结论：miR-210在胃癌组织中的表达明显高于癌旁正常组织，可能与胃癌的发生、发展及预后有关。miR-210有望成为胃癌新的诊断标志物及治疗靶点。

Abstract

Background and purpose: miR-210 was closely related to the occurrence and development of gastric cancer

but its mechanism and clinical significance were still not clear. The purpose of this study was to explore the expression of miR-210 in gastric cancer tissues and its clinical significance. Methods: The expression of miR-210 was detected in gastric cancer tissues and the corresponding adjacent tissues. The relationship between the expression of miR-210 and clinical pathological factors and prognosis was analyzed. Results: Real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) showed that the expression of miR-210 in gastric cancer was higher than that in adjacent tissue

and there was a significant difference between the two groups (P0.05). The expression of miR-210 was closely related to tumor size

lymph node metastasis and TNM stage

but was not related to age

gender

tumor differentiation and depth of invasion. The 5-year survival rate of patients with low miR-210 expression was 48.2%

whereas the 5-year survival rate of patients with high miR-210 expression was 30.4% (χ

=4.216

P=0.040). Conclusion: The expression of miR-210 in gastric cancer was higher than that in adjacent tissues

and maybe related to the development and prognosis of gastric cancer. miR-210 is expected to be a new diagnostic marker and therapeutic target for gastric cancer.

关键词

Keywords

references

Views

2292

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study

Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

Artificial intelligence in gastric cancer diagnosis, treatment and prognostic prediction: current application and future perspective

The prognostic value of high expression of FKBP1A in gastric cancer and the regulatory effect of targeted PI3K/AKT on glucose metabolism

The mechanism of m6Am-modifying enzyme PCIF1 regulating target gene ACOT8 in gastric cancer progression

Related Author

Ximei ZHANG

Yixuan ZHOU

Yan ZHAO

Xuan ZHOU

Xudong WANG

Yingbin YAN

Peiguo WANG

Sumei FAN

Related Institution

Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors

Tianjin Clinical Research Center for Malignant Tumors

Stomatological Clinical College of Tianjin Medical University

Department of Oral and Maxillofacial-Head and Neck Surgery, Tianjin Stomatological Hospital Affiliated to Nankai University School of Medicine

Tianjin Key Laboratory of Oral and Maxillofacial Functional Reconstruction

AI问答

⁰